Case Study: CardioX Phase III Clinical Efficacy & Safety Analysis
This project involved the end-to-end analysis of a Phase III, randomized, double-blind clinical trial for CardioX, a novel antihypertensive drug. The dataset contained records for 997 subjects across 4 international sites (USA, France, Canada, Australia).
Clinical Trial Site and Subject Performance Dashboard
This project analyzes operational performance and data quality across clinical trial sites using a simulated multi-country dataset. As a Clinical Data Analyst, I built an Excel-based dashboard that tracks key metrics such as screening numbers, enrollment rate, randomization progress, screen failure rate, data query rates, and overall site performance.